Compare GRDN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRDN | HAE |
|---|---|---|
| Founded | 2004 | 1971 |
| Country | United States | United States |
| Employees | 3600 | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | N/A | 1996 |
| Metric | GRDN | HAE |
|---|---|---|
| Price | $37.00 | $61.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | $40.25 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 563.6K | 546.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.54 |
| EPS | N/A | ★ 2.46 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.63 | $5.23 |
| P/E Ratio | $117.77 | ★ $24.55 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.17 | $47.32 |
| 52 Week High | $41.36 | $87.32 |
| Indicator | GRDN | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 50.79 | 60.34 |
| Support Level | $28.07 | $48.47 |
| Resistance Level | $37.78 | $66.86 |
| Average True Range (ATR) | 1.48 | 1.77 |
| MACD | -0.14 | 0.75 |
| Stochastic Oscillator | 40.32 | 98.19 |
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.